FDA Approves Hulio®, A Biosimiar To Humira®The U.S. Food and Drug Administration (FDA) has approved Hulio®, a biosimilar to Humira®. Hulio (adalimumab-fkjp) will be the sixth Humira biosimilar approved for the treatment of many inflammatory conditions... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one... By Editorial TeamBookmark for later Reactions 0 reactions Comments2 comments
Now Closed – Fatigue and Health SurveyThe 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon." Exhaustion, tiredness, weariness... fatigue. We know... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Take the Chronic Pain In America Survey! (Now Closed)We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with chronic pain is painful. But there is so much more... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Introducing our New Accessibility FeatureYou may have noticed that we added a new accessibility feature to our websites. This feature will allow community members to change the size, color, or contrast of the text... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Take The Clinical Trial Patient Voice Survey (Now Closed)Have you participated in a clinical trial? Are you interested in participating in future clinical trials? We want to hear more about your experience! PlaquePsoriasis.com/Health Union is teaming up with... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves SKYRIZI™ to treat Plaque PsoriasisOn Tuesday, April 23, 2019, the United States Food and Drug Administration (FDA) announced that it had approved the drug SKYRIZI to treat certain adults with plaque psoriasis.1 Since no... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Approval of Biosimilar Hyrimoz™ (adalimumab-adaz)The U.S. Food and Drug Administration (FDA) has approved Hyrimoz for the treatment of plaque psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), Crohn’s disease in adults, ulcerative... By Emily DownwardBookmark for later Reactions 0 reactions Comments0 comments
How's Your Relationship with Your Doctor? Take our Survey!Do you feel heard by your doctor? Do your questions get answered? We want to hear from you! We’re conducting a survey to learn more about your relationship with your... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Cimzia® (certolizumab pegol) Now Approved for Plaque PsoriasisCimzia was recently approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis. Cimzia has been previously approved to treat other inflammatory conditions, including... By Emily DownwardBookmark for later Reactions 0 reactions Comments0 comments
Take the Clinical Trial Patient Experience Survey!Have you participated in a clinical trial? We want to hear more about your experience! We are conducting a short survey to understand how patients are involved in the clinical... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
New Look, Same Great Community!You might notice a few changes in the way things look when you visit PlaquePsoriasis.com. Never fear! You still have the same tools for finding info and connecting with others... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves ILUMYA™ for PsoriasisThe US Food and Drug Administration (FDA) has approved the new drug, ILUMYA™, for treatment of plaque psoriasis. ILUMYA, an injectable, has demonstrated significant effectiveness in clinical trials. The announcement... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Take the Online Health Resource Survey!Managing a chronic health condition like plaque psoriasis can be overwhelming at times. How do you find reliable information? Where do you go to find a supportive community? What features... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
